Ngā hua rapu - Jean‐Ralph Zahar
- E whakaatu ana i te 1 - 20 hua o te 42
- Haere ki te Whārangi Whai Ake
-
1
-
2
-
3
When and How to Use MIC in Clinical Practice? mā Sophie Magréault, Françoise Jauréguy, Étienne Carbonnelle, Jean‐Ralph Zahar
I whakaputaina 2022Revisão -
4
-
5
Treatment of severe hospital-acquired and ventilator-associated pneumonia: a systematic review of inclusion and judgment criteria used in randomized controlled trials mā Emmanuel Weiss, Wafa Essaied, Christophe Adrie, Jean‐Ralph Zahar, Jean‐François Timsit
I whakaputaina 2017Revisão -
6
-
7
Invasive fungal diseases during COVID-19: We should be prepared mā Jean‐Pierre Gangneux, M.-E. Bougnoux, Éric Dannaoui, Muriel Cornet, Jean‐Ralph Zahar
I whakaputaina 2020Artigo -
8
-
9
-
10
Contact Precautions for Preventing Nosocomial Transmission of Extended-Spectrum β Lactamase–Producing Escherichia coli: A Point/Counterpoint Review mā Sarah Tschudin‐Sutter, Jean‐Christophe Lucet, Nico T. Mutters, Evelina Tacconelli, Jean Ralph Zahar, Stéphan Harbarth
I whakaputaina 2017Revisão -
11
-
12
Screening for Intestinal Carriage of Extended-spectrum Beta-lactamase–producing Enterobacteriaceae in Critically Ill Patients: Expected Benefits and Evidence-based Controversies mā Jean‐Ralph Zahar, Stijn Blot, Patrice Nordmann, Romain Martischang, Jean‐François Timsit, Stephan Harbarth, François Barbier
I whakaputaina 2018Revisão -
13
Infections caused by naturally AmpC-producing Enterobacteriaceae: Can we use third-generation cephalosporins? A narrative review mā Assaf Mizrahi, Thibaud Delerue, H. Morel, Alban Le Monnier, Étienne Carbonnelle, B. Pilmis, Jean‐Ralph Zahar
I whakaputaina 2019Revisão -
14
Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients mā François Barbier, Sami Hraiech, Solen Kernéis, Nathanaël Veluppillai, Olivier Pajot, Julien Poissy, Damien Roux, Jean‐Ralph Zahar
I whakaputaina 2023Revisão -
15
Corticosteroids as Adjunctive Therapy for Severe Pneumocystis carinii Pneumonia in Non-Human Immunodeficiency Virus-Infected Patients: Retrospective Study of 31 Patients mā Christophe Delclaux, Jean‐Ralph Zahar, Gibba Amraoui, Ghislaine Leleu, François Lebargy, Laurent Brochard, Benoı̂t Schlemmer, Christian Brun‐Buisson
I whakaputaina 1999Artigo -
16
-
17
Delayed treatment contributes to mortality in ICU patients with severe active pulmonary tuberculosis and acute respiratory failure mā Jean-Ralph Zahar, Élie Azoulay, Elise Klement-Frutos, Arnaud de Lassence, Jean-Christophe Lucet, B. Régnier, Benoı̂t Schlemmer, Jean‐Pierre Bédos
I whakaputaina 2001Artigo -
18
Ultraviolet disinfection robots to improve hospital cleaning: Real promise or just a gimmick? mā Magda Diab-El Schahawi, Walter Zingg, Martine De Vos, H. Humphreys, Lorena López‐Cerero, Astrid Fueszl, Jean Ralph Zahar, Elisabeth Presterl
I whakaputaina 2021Carta -
19
-
20
Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events mā Jean‐Ralph Zahar, Maïté Garrouste-Orgeas, Aurélien Vésin, Carole Schwebel, A. Bonadona, François Philippart, Claire Ara-Somohano, Benoît Misset, Jean‐François Timsit
I whakaputaina 2013Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Intensive care medicine
Biology
Microbiology
Antibiotics
Intensive care
Intensive care unit
Antibiotic resistance
Disease
Emergency medicine
Pneumonia
Bacteria
Coronavirus disease 2019 (COVID-19)
Genetics
Infectious disease (medical specialty)
Pathology
Environmental health
Engineering
Gene
Mechanical ventilation
Virology
Cohort study
Escherichia coli
Outbreak
Anesthesia
Anesthesiology
Antimicrobial
Confidence interval
Incidence (geometry)